BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36103774)

  • 1. Generation of a gene-corrected human iPSC line (CSUASOi004-A-1) from a retinitis pigmentosa patient with heterozygous c.2699 G>A mutation in the PRPF6 gene.
    Liang Y; Sun X; Duan C; Zhou Y; Cui Z; Ding C; Gu J; Mao S; Ji S; Chan HF; Tang S; Chen J
    Stem Cell Res; 2022 Oct; 64():102911. PubMed ID: 36103774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
    Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation.
    Liang Y; Tan F; Sun X; Cui Z; Gu J; Mao S; Chan HF; Tang S; Chen J
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa.
    Tanackovic G; Ransijn A; Ayuso C; Harper S; Berson EL; Rivolta C
    Am J Hum Genet; 2011 May; 88(5):643-9. PubMed ID: 21549338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
    Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
    Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP-related retinitis pigmentosa-nanophthalmos syndrome.
    Mora-Roldan GA; Nava J; Gazarian K; Zenteno JC
    Stem Cell Res; 2024 Mar; 75():103309. PubMed ID: 38217995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The manner of decay of genetically defective EYS gene transcripts in photoreceptor-directed fibroblasts derived from retinitis pigmentosa patients depends on the type of mutation.
    Seko Y; Iwanami M; Miyamoto-Matsui K; Takita S; Aoi N; Umezawa A; Kato S
    Stem Cell Res Ther; 2018 Oct; 9(1):279. PubMed ID: 30359287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of splicing factors in retinitis pigmentosa: links to cilia.
    Maxwell DW; O'Keefe RT; Roy S; Hentges KE
    Biochem Soc Trans; 2021 Jun; 49(3):1221-1231. PubMed ID: 34060618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene.
    Bai X; Chen J; Zhao X; Zhu X; Ding X; Zhang T; Jiang M; Sun X
    Stem Cell Res; 2024 Jun; 77():103390. PubMed ID: 38507880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
    Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
    Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
    Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A
    Stanković D; Claudius AK; Schertel T; Bresser T; Uhlirova M
    Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32424050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
    Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
    Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Correction Recovers Phagocytosis in Retinal Pigment Epithelium Derived from Retinitis Pigmentosa-Human-Induced Pluripotent Stem Cells.
    Artero-Castro A; Long K; Bassett A; Ávila-Fernandez A; Cortón M; Vidal-Puig A; Jendelova P; Rodriguez-Jimenez FJ; Clemente E; Ayuso C; Erceg S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A).
    Ding Y; Carvalho E; Murphy C; McInerney V; Krawczyk J; O'Brien T; Howard L; Cai L; Shen S
    Stem Cell Res; 2020 Mar; 43():101665. PubMed ID: 31954326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted RP9 ablation and mutagenesis in mouse photoreceptor cells by CRISPR-Cas9.
    Lv JN; Zhou GH; Chen X; Chen H; Wu KC; Xiang L; Lei XL; Zhang X; Wu RH; Jin ZB
    Sci Rep; 2017 Feb; 7():43062. PubMed ID: 28216641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
    de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.